NASDAQ : VANI
Vivani Medical, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 102.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.25M | 9.43M | 8.93M | 10.00M | 5.37M | 2.32M |
| Research & Development | 18.11M | 18.13M | 15.74M | 16.97M | 14.17M | 11.00M |
| Operating Expenses | 27.36M | 27.56M | 24.68M | 26.96M | 19.54M | 13.32M |
| Operating Income | -27.36M | -27.56M | -24.68M | -26.96M | -19.54M | -13.32M |
| Other Non Operating Income (Expenses) | 1.04M | 947.00K | 1.19M | 1.31M | 475.00K | 550.00K |
| EBT Excluding Unusual Items | -26.31M | -26.61M | -23.49M | -25.65M | -19.07M | -12.77M |
| Legal Settlements | -1.70M | |||||
| Other Unusual Items | 6.88M | |||||
| Pretax Income | -26.31M | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M |
| Earnings From Continuing Operations | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M | |
| Net Income | -26.31M | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M |
| Net Income to Common | -26.31M | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M |
| Shares Outstanding (Basic) | 74.87M | 62.39M | 54.98M | 50.85M | 38.24M | 33.09M |
| Shares Outstanding (Diluted) | 74.87M | 62.39M | 54.98M | 50.85M | 38.24M | 33.09M |
| EPS (Basic) | -0.35 | -0.43 | -0.43 | -0.50 | -0.36 | -0.39 |
| EPS (Diluted) | -0.35 | -0.43 | -0.43 | -0.50 | -0.36 | -0.39 |
| Free Cash Flow | -26.50M | -25.49M | -21.34M | -24.59M | -19.12M | -11.52M |
| Free Cash Flow Per Share | -0.35 | -0.41 | -0.39 | -0.48 | -0.50 | -0.35 |
| EBITDA | -26.88M | -27.13M | -24.28M | -26.61M | -19.16M | -12.98M |
| D&A For EBITDA | 478.00K | 424.00K | 400.00K | 357.00K | 381.00K | 345.00K |
| EBIT | -27.36M | -27.56M | -24.68M | -26.96M | -19.54M | -13.32M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.89M | 16.23M | 18.35M | 20.65M | 45.08M | 2.18M |
| Cash & Short-Term Investments | 19.89M | 16.23M | 18.35M | 20.65M | 45.08M | 2.18M |
| Other Receivables | 709.00K | 654.00K | 253.00K | |||
| Receivables | 709.00K | 654.00K | 253.00K | |||
| Prepaid Expenses | 1.03M | 1.01M | 1.84M | 2.41M | 2.45M | 291.00K |
| Total Current Assets | 21.64M | 17.90M | 20.44M | 23.06M | 47.53M | 2.47M |
| Property, Plant & Equipment | 19.02M | 20.11M | 19.65M | 21.34M | 1.96M | 2.78M |
| Other Long-Term Assets | 985.00K | 1.39M | 1.47M | 1.39M | 1.64M | 200.00K |
| Total Assets | 41.64M | 39.39M | 41.56M | 45.80M | 51.13M | 5.45M |
| Accounts Payable | 1.20M | 1.03M | 817.00K | 542.00K | 1.18M | 281.00K |
| Accrued Expenses | 1.61M | 1.77M | 1.81M | 1.79M | 4.30M | 895.00K |
| Current Portion of Leases | 1.84M | 1.79M | 1.35M | 1.38M | 955.00K | 910.00K |
| Current Unearned Revenue | 335.00K | 335.00K | 335.00K | 335.00K | 335.00K | |
| Other Current Liabilities | 1.68M | 1.68M | 1.68M | 1.68M | 50.00K | |
| Total Current Liabilities | 6.66M | 6.60M | 5.99M | 5.72M | 6.82M | 2.09M |
| Long-Term Leases | 16.01M | 17.06M | 17.96M | 19.31M | 902.00K | |
| Total Liabilities | 22.67M | 23.66M | 23.95M | 25.04M | 6.82M | 2.99M |
| Common Stock | 9.00K | 8.00K | 6.00K | 5.00K | 5.00K | 54.65M |
| Additional Paid-In Capital | 180.61M | 164.22M | 139.48M | 119.05M | 117.05M | 6.71M |
| Retained Earnings | -161.68M | -148.53M | -121.92M | -98.44M | -72.79M | -58.90M |
| Comprehensive Income & Other | 32.00K | 30.00K | 48.00K | 140.00K | 35.00K | |
| Shareholders' Equity | 18.97M | 15.73M | 17.61M | 20.76M | 44.31M | 2.46M |
| Total Liabilities & Equity | 41.64M | 39.39M | 41.56M | 45.80M | 51.13M | 5.45M |
| Total Debt | 17.86M | 18.86M | 19.31M | 20.70M | 955.00K | 1.81M |
| Net Cash (Debt) | 2.04M | -2.62M | -961.00K | -42.00K | 44.12M | 366.00K |
| Net Cash Per Share | 0.03 | -0.04 | -0.02 | -0.00 | 1.15 | 0.01 |
| Filing Date Shares Outstanding | 90.20M | 84.65M | 59.24M | 54.98M | 50.74M | 12.19M |
| Total Common Shares Outstanding | 89.41M | 76.43M | 59.23M | 51.03M | 50.74M | 12.19M |
| Working Capital | 14.98M | 11.30M | 14.46M | 17.34M | 40.71M | 383.00K |
| Book Value Per Share | 0.21 | 0.21 | 0.30 | 0.41 | 0.87 | 0.20 |
| Tangible Book Value | 18.97M | 15.73M | 17.61M | 20.76M | 44.31M | 2.46M |
| Tangible Book Value Per Share | 0.21 | 0.21 | 0.30 | 0.41 | 0.87 | 0.20 |
| Machinery | 2.98M | 4.54M | 4.30M | 3.87M | 3.53M | 3.18M |
| Construction In Progress | 1.15M | 1.36M | 299.00K | |||
| Leasehold Improvements | 12.00K | 12.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -26.31M | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M |
| Depreciation & Amortization | 478.00K | 424.00K | 400.00K | 357.00K | 381.00K | 345.00K |
| Loss (Gain) From Sale of Assets | 121.00K | |||||
| Asset Writedown & Restructuring Costs | 60.00K | |||||
| Stock-Based Compensation | 1.37M | 1.48M | 1.61M | 1.86M | 1.30M | 1.67M |
| Other Operating Activities | -235.00K | 152.00K | 276.00K | 904.00K | -6.91M | -627.00K |
| Change in Accounts Payable | -1.12M | -222.00K | 248.00K | -602.00K | -1.94M | 13.00K |
| Change in Other Net Operating Assets | 520.00K | 451.00K | 106.00K | -691.00K | 2.28M | 423.00K |
| Operating Cash Flow | -25.30M | -24.32M | -20.79M | -23.70M | -18.79M | -10.95M |
| Capital Expenditures | -1.20M | -1.17M | -556.00K | -887.00K | -338.00K | -572.00K |
| Investing Cash Flow | -1.20M | -1.17M | -556.00K | -887.00K | -338.00K | -572.00K |
| Long-Term Debt Issued | 355.00K | 426.00K | 8.00M | |||
| Total Debt Issued | 355.00K | 355.00K | 426.00K | 8.00M | ||
| Long-Term Debt Repaid | -344.00K | -189.00K | ||||
| Net Debt Issued (Repaid) | 35.00K | 11.00K | 237.00K | 8.00M | ||
| Issuance of Common Stock | 39.05M | 23.29M | 18.82M | 133.00K | 16.00K | 11.62M |
| Other Financing Activities | -28.00K | 55.37M | ||||
| Financing Cash Flow | 39.09M | 23.27M | 19.05M | 133.00K | 63.39M | 11.62M |
| Foreign Exchange Rate Adjustments | 68.00K | 99.00K | -14.00K | 3.00K | -1.00K | |
| Net Cash Flow | 12.65M | -2.12M | -2.30M | -24.45M | 44.26M | 97.00K |
| Free Cash Flow | -26.50M | -25.49M | -21.34M | -24.59M | -19.12M | -11.52M |
| Free Cash Flow Per Share | -0.35 | -0.41 | -0.39 | -0.48 | -0.50 | -0.35 |
| Levered Free Cash Flow | -16.83M | -15.89M | -13.35M | -17.00M | -8.34M | -6.45M |
| Unlevered Free Cash Flow | -16.83M | -15.89M | -13.35M | -17.00M | -8.34M | -6.45M |
| Cash Income Tax Paid | 2.00K | 1.00K | 1.00K | |||
| Change in Working Capital | -599.00K | 229.00K | 354.00K | -1.29M | 338.00K | 436.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 98.32M | 89.73M | 68.71M | 52.05M | 43.11M | |
| Enterprise Value | 96.28M | 105.40M | 68.75M | 48.28M | -7.29M | |
| Last Close Price | 1.09 | 1.23 | 1.16 | 1.02 | 0.85 | |
| PB Ratio | 5.14 | 5.70 | 3.90 | 2.51 | 0.97 | |
| P/TBV Ratio | 5.18 | 5.70 | 3.90 | 2.51 | 0.97 | |
| Debt / Equity Ratio | 0.94 | 1.20 | 1.10 | 1.00 | 0.02 | 0.73 |
| Net Debt / Equity Ratio | -0.11 | 0.17 | 0.06 | 0.00 | -1.00 | -0.15 |
| Net Debt / EBITDA Ratio | 0.08 | -0.10 | -0.04 | -0.00 | 2.30 | 0.03 |
| Net Debt / FCF Ratio | 0.08 | -0.10 | -0.04 | -0.00 | 2.31 | 0.03 |
| Quick Ratio | 3.09 | 2.56 | 3.11 | 3.61 | 6.61 | 1.04 |
| Current Ratio | 3.25 | 2.71 | 3.42 | 4.03 | 6.97 | 1.18 |
| Return on Equity (ROE) | -220.41% | -159.62% | -122.42% | -78.84% | -59.39% | -578.62% |
| Return on Assets (ROA) | -48.48% | -42.55% | -35.31% | -34.77% | -43.17% | -156.08% |
| Return on Capital Employed (ROCE) | -78.20% | -84.00% | -69.40% | -67.30% | -44.10% | -395.70% |
| Earnings Yield | -32.24% | -29.65% | -34.18% | -49.29% | -32.22% | |
| FCF Yield | -26.95% | -28.41% | -31.06% | -47.24% | -44.36% | |
| Buyback Yield / Dilution | -29.54% | -13.47% | -8.12% | -32.98% | -15.56% | -234.38% |